×
About 7,765 results

ALLMedicine™ Urticaria Center

Research & Reviews  1,892 results

Bizarre Cutaneous Ulcers due to Self-Administered Intravenous Dexketoprofen Trometamol.
https://doi.org/10.1177/15347346221074158
The International Journal of Lower Extremity Wounds; Akdogan N, Elcin G et. al.

Jan 18th, 2022 - Systemic non-steroidal anti-inflammatory drug use may result in various cutaneous complications including maculopapular rash, fixed drug eruption, urticaria, and angioedema most frequently. However extensive cutaneous ulcers in relation to intrave...

Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.
https://doi.org/10.1016/j.jaci.2021.12.789
The Journal of Allergy and Clinical Immunology; Chinthrajah RS, Jones SM et. al.

Jan 14th, 2022 - Immunotherapy is promising as an efficacious treatment for food allergy. Other food allergy treatments are also under development. However, adverse allergic events (AE) during treatment, as well as during oral food challenges (OFC) are common and ...

Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT04833855

Jan 13th, 2022 - The primary objective of this study is to evaluate the effect of tezepelumab on improvement in the Urticaria Activity Score over 7 days (UAS7).

P017 Increased Level of Immunoglobulin G in the Development of Adverse Reactions in Pat...
https://doi.org/10.14309/01.ajg.0000798668.44537.26
The American Journal of Gastroenterology; Zvyaglova M, Knyazev O et. al.

Jan 11th, 2022 - Goal: To identify the relationship between the level of immunoglobulins G and E and the development of adverse reaction (AR) in patients with ulcerative colitis (UC) receiving original infliximab (IFХ) and infliximab biosimilar (BS). 35 UC patient...

see more →

Guidelines  6 results

Considerations on biologicals for patients with allergic disease in times of the COVID-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300800
Allergy Vultaggio A, Agache I et. al.

Jun 6th, 2020 - The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pandemic re-shaped doctor-patient interaction and challenged capacities of healthcare systems. It created many issues around the optimal and safest way to treat complex pat...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.

Jan 18th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.

Jun 6th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German ...
https://doi.org/10.1111/j.1524-4725.2010.01495.x
Dermatologic Surgery : Official Publication for American ... Rabe E, Pannier F

Jul 16th, 2010 - Sclerotherapy involves the injection of a sclerosing agent for the elimination of intracutaneous, subcutaneous, and transfascial varicose veins. To update guidelines for sclerotherapy of varicose veins. The guidelines for sclerotherapy of varicose...

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.
https://doi.org/10.1111/j.1398-9995.2009.02179.x
Allergy Zuberbier T, Asero R et. al.

Sep 24th, 2009 - This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 6...

see more →

Drugs  856 results see all →

Clinicaltrials.gov  77 results

Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT04833855

Jan 13th, 2022 - The primary objective of this study is to evaluate the effect of tezepelumab on improvement in the Urticaria Activity Score over 7 days (UAS7).

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to ...
https://clinicaltrials.gov/ct2/show/NCT04180488

Jan 11th, 2022 - The duration of study for each participant will include 2-4 weeks of screening period, 24 weeks of treatment period and 12 weeks of post treatment period.

Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT05170724

Dec 28th, 2021 - The purpose of this Managed Access Program (MAP) Cohort Treatment Plan is to provide access to remibrutinib for adult patients with chronic spontaneous urticaria (CSU)

A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT04538794

Dec 20th, 2021 - The purpose of the study is to explore the safety, pharmacodynamics, and pharmacokinetics of ascending doses of CDX-0159 in patients with Chronic Spontaneous Urticaria who remain symptomatic despite treatment with antihistamines. There is a screen...

Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
https://clinicaltrials.gov/ct2/show/NCT04976192

Dec 17th, 2021 - This is a multicenter, randomized, double-blind study to demonstrate similar efficacy and safety of TEV-45779 compared to XOLAIR administered sc at doses of 300 mg or 150 mg every 4 weeks for 24 weeks (6 treatments) in patients with Chronic Idiopa...

see more →

News  269 results

25-year-old woman • abdominal pain • urticarial rash • recent influenza immunization • Dx?
https://www.mdedge.com/familymedicine/article/249695/immunology
MDedge Family Medicine; Danielle Yee, MD, Adam Skrynski, MD et. al.

Dec 8th, 2021 - THE CASE A 25-year-old woman presented to an infectious diseases (ID) physician with a 4-day history of symptoms following receipt of a quadrivalent influenza vaccine. Two hours after receiving the vaccine, the patient experienced abdominal pain.

Contact Allergy to Topical Medicaments, Part 1: A Double-edged Sword
https://www.mdedge.com/dermatology/article/248375/contact-dermatitis/contact-allergy-topical-medicaments-part-1-double
Ashley Ng, BS, Amber Reck Atwater, MD et. al.

Nov 8th, 2021 - Topical medications frequently are prescribed in dermatology and provide the advantages of direct skin penetration and targeted application while typically sparing patients from systemic effects. Adverse cutaneous effects include allergic contact.

Expert Recommendations on the Diagnosis and Management of Long COVID
https://www.medscape.com/viewarticle/960243

Oct 5th, 2021 - It is estimated that one million people in the UK are currently living with long COVID, and with the total number of UK COVID-19 cases nearing 8 million, the further implications of long COVID for patients and healthcare services is uncertain. As ...

COVID-19: 2 More Cases of Mucosal Skin Ulcers Reported in Male Teens
https://www.medscape.com/viewarticle/959283

Sep 22nd, 2021 - Irish dermatologists are reporting two more cases of a rare skin ulcer known as reactive infectious mucocutaneous eruption (RIME) in teenage males who were infected with COVID-19. A similar case in an adolescent, also with ulcers affecting the mou...

Study Finds Most Adverse Events From Microneedling Are Minimal
https://www.medscape.com/viewarticle/958410

Sep 9th, 2021 - Most adverse events associated with the practice of microneedling are transient, and most adverse effects and allergic reactions occur in conjunction with combination therapies, according to the results of a systematic review of nearly 3,000 patie...

see more →

Patient Education  6 results see all →